Journal issue overview 9/2014 Internal Medicine

680

Long-term acting insulin analogues and the risks of hypoglycemic incidence

Alena Adamíková, Jaroslav Rybka

684

Factors causing damage and destruction of beta-cells of the islets of Langerhans in the pancreas

Michal Anděl, Vlasta Němcová, Nela Pavlíková, Jana Urbanová, Marie Čecháková, Andrea Havlová, Radka Straková, Livia Večeřová, Václav Mandys, Jan Kovář, Petr Heneberg, Jan Trnka, Jan Polák

691

Calcium, vitamin D and health

Jaroslav Blahoš, Václav Vyskočil

697

SOLOSTAR study demonstrated high levels of patient satisfaction with the use of the insulin pen SoloStar^® in the Czech Republic

Tomáš Edelsberger, Michal Policar, Dita Pospíšilová, Jana Psottová, Jana Houdová, Denisa Janíčková Žďárská

705

News and perspectives in insulin treatment

Martin Haluzík

712

Basal insulin glargine using a basal-bolus regimen in a common clinical practice: observational, non-interventional, multicenter, national project LINDA (Lantus in daily practice – safety and efficacy in basal bolus regimen)

Denisa Janíčková Žďárská, Jan Brož, Bohumila Křivská, Zdeněk Rušavý, Milan Kvapil

720

AGEs and RAGE – advanced glycation end-products and their receptor in questions and answers

Marta Kalousová, Tomáš Zima

725

Liver, kidneys and diabetes: three faces of HNF1B gene deficit

Jan Lebl, Stanislava Koloušková, Petra Dušátková, Ondřej Cinek, Lenka Dušátková, Tomáš Dědič, Radana Kotalová, Zdeněk Šumník, Tomáš Seeman, Štěpánka Průhová

730

Problems of differential diagnosis of paraneoplastic hypoglycaemia

Marián Mokáň, Peter Galajda

737

Hypoglycemia as a limitation to the treatment of diabetes mellitus

Jindřich Olšovský

742

Changes of bone metabolism in diabetics

Vladimír Palička, Jana Lesná, Ladislava Pavlíková

746

Insulin resistance – its causes and therapy possibilities

Terezie Pelikánová